Year: 2019
Type: conference-abstract
Abstract: 2024 Background: A major impediment to improving neuro-oncology outcomes is poor clinical trial accrual. Methods: We convened a multi-stakeholder group including Society for Neuro-Oncology, Response Assessment in Neuro-Oncology, patient advocacy groups, clinical trial cooperative groups, and other partners to determine how we can improve trial accrual. Results: We describe selected factors contributing to poor trial accrual and possible solutions. Conclusions: We will implement strategies with the intent to double trial accrual over the next 5 years. [Table: see text]
Source: Journal of Clinical Oncology
Authors: Eudocia Quant Lee, Ugonma Nnenna Chukwueke, Shawn L. Hervey-Jumper, John Frederick De Groot, Jose Pablo Leone, Terri S. Armstrong, Susan Marina Chang, David Arons, Kathy Rose Oliver, Evanthia Galanis, Bret Edward Buckley Friday, Nancy U. Lin, Minesh P. Mehta, Marta Penas-Prado, Michael A. Vogelbaum, Solmaz Sahebjam, Martin J. Van Den Bent, Michael Weller, David A. Reardon, Patrick Y. Wen
Institutions: Dana-Farber Cancer Institute, Massachusetts General Hospital, University of California, San Francisco, The University of Texas MD Anderson Cancer Center, The University of Texas Health Science Center at Houston, National Brain Tumor Society, Mayo Clinic, Baptist Hospital of Miami, Baptist Health South Florida, Cleveland Clinic, University of South Florida, Moffitt Cancer Center, Erasmus MC, Erasmus MC Cancer Institute, University of Zurich, University Hospital Zurich, Harvard University, Dana-Farber/Harvard Cancer Center, Dana-Farber Brigham Cancer Center
Language: English
Topic: Ethics in Clinical Research
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2947358682